Status:
COMPLETED
The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
Coronavirus Disease 2019
Character of the Severe Patients
Eligibility:
All Genders
20-100 years
Brief Summary
To investigate the difference of the difference between the nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the fatal Patients .The cross sectional study was undertaken to compare the clinic...
Eligibility Criteria
Inclusion
- The patients with Coronavirus Disease 2019
- Positive result on real-time reverse-transcriptase-polymerase-chain-reaction
- Positive result on chest computed tomography
Exclusion
- No
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04403009
Start Date
February 1 2020
End Date
June 20 2020
Last Update
March 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Guangzhou Medical University
Guanzhou, Guangdong, China, 520120
2
Hankou Hospital
Wuhan, Hubei, China, 430014